Multiple sclerosis and type 1 diabetes in Sardinia.
作者信息
de Craen Anton J M, Huizinga Tom W J, Westendorp Rudi G J
出版信息
Lancet. 2002 Oct 19;360(9341):1253. doi: 10.1016/S0140-6736(02)11258-X.
Abstract
摘要
相似文献
1
Multiple sclerosis and type 1 diabetes in Sardinia.
Lancet. 2002 Oct 19;360(9341):1253. doi: 10.1016/S0140-6736(02)11258-X.
2
Multiple sclerosis and type 1 diabetes in Sardinia.
Lancet. 2002 Oct 19;360(9341):1253. doi: 10.1016/s0140-6736(02)11257-8.
3
Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study.
Lancet. 2002 Apr 27;359(9316):1461-5. doi: 10.1016/S0140-6736(02)08431-3.
4
Multiple sclerosis and type 1 diabetes: an unlikely alliance.
Lancet. 2002 Apr 27;359(9316):1450-1. doi: 10.1016/S0140-6736(02)08464-7.
5
Multiple sclerosis and Type I diabetes.
Diabetologia. 2002 Dec;45(12):1735-6. doi: 10.1007/s00125-002-0967-6. Epub 2002 Nov 16.
6
[Diabetes mellitus type 1 and multiple sclerosis. Are they common risk factors?].
Med Monatsschr Pharm. 2007 Apr;30(4):159-60.
7
Sardinia, a high-risk area for multiple sclerosis: a prevalence and incidence study in the district of Alghero.
Ann Neurol. 1987 Feb;21(2):190-4. doi: 10.1002/ana.410210212.
8
Interferon-gamma gene polymorphism-associated risk for multiple sclerosis in Sardinia.干扰素-γ基因多态性与撒丁岛多发性硬化症的患病风险
Ann Neurol. 1998 Nov;44(5):841-2. doi: 10.1002/ana.410440525.
9
From Sardinia to Japan: update on the role of MAP in multiple sclerosis.从撒丁岛到日本：MAP在多发性硬化症中作用的最新进展
Future Microbiol. 2019 May;14:643-646. doi: 10.2217/fmb-2019-0102. Epub 2019 May 31.
10
Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.多发性硬化症：表达BDCA-2和BDCA-4的循环浆细胞样树突状细胞比例降低，且对1型单纯疱疹病毒的反应中白细胞介素-6和白细胞介素-10的产生减少。
Mult Scler. 2008 Nov;14(9):1199-207. doi: 10.1177/1352458508094401. Epub 2008 Jul 24.
Zotero 插件